Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Paterna Biosciences Inc. is active in the Biotechnology & Pharmaceuticals technology area with 1 pending office action currently on file. This single action is assigned to 1 distinct examiner, reflecting a narrow prosecution front. The matter is situated within 1 distinct art unit, which aligns with the specialized nature of the biotechnology sector.
The busiest examiner for the portfolio is WRIGHT, ERIC BRANDON, who is responsible for 1 pending office action. This count of 1 matches the total number of pending office actions for the company, indicating that all current prosecution activity is concentrated under this individual. The use of 1 distinct examiner across 1 distinct art unit suggests a highly targeted approach to its intellectual property filings.
With only 1 pending office action, the company's current interaction with the patent office is limited in scale. The data shows that the 1 busiest examiner pending action accounts for the entirety of the pending workload. This focused activity in the Biotechnology & Pharmaceuticals space indicates a specific point of interest rather than a broad-based filing strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WRIGHT, ERIC BRANDON | 1 | — | — |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19257274 | METHOD FOR IN VITRO GENERATION OF HUMAN SPERMATIDS | WRIGHT, ERIC BRANDON | 1632 | §112 | Non-Final OA | — | Pending | Jul 01, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial